To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD
Clinical trial NCT05650320 · COMPLETED
Trial details
- NCT number
- NCT05650320
- Sponsor
- Otsuka Beijing Research Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-17
- Primary completion
- 2024-07-21
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.